Ximoprofen

CAS No. 56187-89-4

Ximoprofen( —— )

Catalog No. M34737 CAS No. 56187-89-4

Ximoprofen is a novel anti-inflammatory compound for the study of spondylitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 851 In Stock
10MG 1169 In Stock
25MG 1729 In Stock
50MG 2279 In Stock
100MG 3060 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ximoprofen
  • Note
    Research use only, not for human use.
  • Brief Description
    Ximoprofen is a novel anti-inflammatory compound for the study of spondylitis.
  • Description
    Ximoprofen is a novel anti-inflammatory compound for the study of spondylitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56187-89-4
  • Formula Weight
    261.32
  • Molecular Formula
    C15H19NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(O)=C1CC(C2=CC=C(C(C(O)=O)C)C=C2)CCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MitoPQ

    MitoPQ (MitoParaquat) is a mitochondria-targeted small molecule compound that selectively enhances mitochondrial superoxide and hydrogen peroxide levels and inhibits insulin-stimulated glucose uptake and translocation of glucose transport protein 4 (GLUT4) to the plasma membrane in adipocytes and myotubes.MitoPQ can be used to MitoPQ can be used to study mitochondrial oxidative stress and regulated GLUT4 transporter.

  • Biotin-Bradykinin

    Biotin-Bradykinin

  • Luvadaxistat

    Luvadaxistat (TAK-831) is an orally active, potent and highly selective inhibitor of D-amino acid oxidase (DAAO) with an IC50 value of 14 nM for the oxidative deamination of D-serine.Luvadaxistat is used in the study of schizophrenia and cognitive disorders.